Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 1386197)

Published in Am J Trop Med Hyg on July 01, 1992

Authors

R E Thomas1, W J Simpson, L L Perry, T G Schwan

Author Affiliations

1: Department of Biological Sciences, University of Notre Dame, Indiana.

Articles by these authors

(truncated to the top 100)

Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1995) 4.68

Antigenic changes of Borrelia burgdorferi as a result of in vitro cultivation. J Infect Dis (1987) 3.66

Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas. Science (1996) 3.65

A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis (1989) 3.53

Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi. Microb Pathog (1990) 3.24

Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun (1999) 2.91

Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol (1990) 2.87

Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol (1991) 2.71

Borrelia burgdorferi erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun (1998) 2.67

Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi). Infect Immun (1989) 2.58

Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol (1987) 2.54

Rickettsia peacockii sp. nov., a new species infecting wood ticks, Dermacentor andersoni, in western Montana. Int J Syst Bacteriol (1997) 2.34

Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals. J Clin Microbiol (1991) 2.32

New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J Clin Microbiol (1993) 2.04

Characterization of an endosymbiont infecting wood ticks, Dermacentor andersoni, as a member of the genus Francisella. Appl Environ Microbiol (1997) 1.82

Identification of a protein in several Borrelia species which is related to OspC of the Lyme disease spirochetes. J Clin Microbiol (1993) 1.80

Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. FEMS Microbiol Lett (1994) 1.77

Evaluation of the role of the Yersinia pestis plasminogen activator and other plasmid-encoded factors in temperature-dependent blockage of the flea. J Infect Dis (1998) 1.75

Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans. J Clin Microbiol (1991) 1.70

The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer (1998) 1.65

Homology between Borrelia burgdorferi OspC and members of the family of Borrelia hermsii variable major proteins. Gene (1994) 1.61

Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete. Scand J Infect Dis Suppl (1991) 1.60

Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis (1998) 1.59

Lethal effect of Rickettsia rickettsii on its tick vector (Dermacentor andersoni). Appl Environ Microbiol (1999) 1.57

Borrelia burgdorferi contains repeated DNA sequences that are species specific and plasmid associated. Infect Immun (1990) 1.57

Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis. J Clin Microbiol (2000) 1.55

Molecular and immunological analysis of a polymorphic periplasmic protein of Borrelia burgdorferi. J Clin Microbiol (1991) 1.48

Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun (1998) 1.47

Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol (1983) 1.46

Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo. J Immunol (1978) 1.40

Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun (1998) 1.40

Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg (1981) 1.35

Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants. J Immunol (1980) 1.35

Identification of Borrelia burgdorferi and B. hermsii using DNA hybridization probes. J Clin Microbiol (1989) 1.33

Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am J Trop Med Hyg (1990) 1.31

Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer (1994) 1.27

Medulloblastoma in adults. Int J Radiat Oncol Biol Phys (1995) 1.26

Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J Virol (1990) 1.24

Quantifying the magnetic advantage in magnetotaxis. Biophys J (2006) 1.23

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid (1996) 1.23

Estimation of vector infectivity rates for plague by means of a standard curve-based competitive polymerase chain reaction method to quantify Yersinia pestis in fleas. Am J Trop Med Hyg (1998) 1.19

Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies. J Exp Med (1982) 1.19

Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer (1993) 1.19

Identification and characterization of Lyme disease spirochetes, Borrelia burgdorferi sensu lato, isolated in Korea. J Clin Microbiol (1993) 1.18

Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys (1996) 1.16

Identification of a Yersinia pestis-specific DNA probe with potential for use in plague surveillance. J Clin Microbiol (1988) 1.13

Detection of Rickettsia rickettsii in saliva, hemolymph and triturated tissues of infected Dermacentor andersoni ticks by polymerase chain reaction. Mol Cell Probes (1992) 1.12

DNA typing of rickettsiae in naturally infected ticks using a polymerase chain reaction/restriction fragment length polymorphism system. Am J Trop Med Hyg (1994) 1.12

The relapsing fever spirochete Borrelia hermsii contains multiple, antigen-encoding circular plasmids that are homologous to the cp32 plasmids of Lyme disease spirochetes. Infect Immun (2000) 1.10

Mechanisms of regulation of cell-mediated immunity: anti-I-A alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivo. Clin Immunol Immunopathol (1980) 1.10

Dental changes in osteopetrosis. Oral Surg Oral Med Oral Pathol (1972) 1.09

Regulation of the immune response to tumor antigen. Am J Pathol (1979) 1.09

Adhesion to and invasion of cultured tick (Acarina: Ixodidae) cells by Borrelia burgdorferi (Spirochaetales: Spirochaetaceae) and maintenance of infectivity. J Med Entomol (1993) 1.09

Cloning and sequence analysis of zooA, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin. Gene (1997) 1.07

Changes in antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete, during persistent infection in mice. Can J Microbiol (1991) 1.06

Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun (2001) 1.06

Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera. Proc Natl Acad Sci U S A (1979) 1.03

Variable small protein (Vsp)-dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes. Mol Microbiol (2000) 1.02

Antigen presentation by epidermal Langerhans cells: loss of function following ultraviolet (UV) irradiation in vivo. Clin Immunol Immunopathol (1982) 1.02

Spinal cord ependymomas: a retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys (1993) 0.99

Tick-borne relapsing fever in British Columbia, Canada: first isolation of Borrelia hermsii. J Clin Microbiol (1998) 0.99

Use of DNA hybridizations probes for detection of the plague bacillus (Yersinia pestis) in fleas (Siphonaptera: Pulicidae and Ceratophyllidae). J Med Entomol (1989) 0.98

Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J Clin Invest (2001) 0.98

Can protracted relapsing fever resemble Lyme disease? Med Hypotheses (1991) 0.97

Distribution of suspected tick vectors and reported cases of Rocky Mountain spotted fever in California. Am J Epidemiol (1976) 0.97

M-type 57 group A streptococcus bacteriocin. Can J Microbiol (1983) 0.95

Ectoparasites (sucking lice, fleas and ticks) of small mammals in southeastern Kenya. Med Vet Entomol (2009) 0.95

The role of external radiation in the management of papillary and follicular thyroid cancer. Am J Surg (1978) 0.95

Clinical implications of delayed growth of the Lyme borreliosis spirochete, Borrelia burgdorferi. Acta Trop (1990) 0.94

Cystitis induced by infection with the Lyme disease spirochete, Borrelia burgdorferi, in mice. Am J Pathol (1992) 0.94

T cell subset interactions in the regulation of syngeneic tumor immunity. Fed Proc (1981) 0.94

Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells. J Immunol (1978) 0.92

The pregnant resident: career conflict? J Am Med Womens Assoc (1983) 0.91

Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum. Am J Pathol (1978) 0.91

The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice. Am J Pathol (1981) 0.90

Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol (1996) 0.89

Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients. J Immunol (1985) 0.89

Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol (1991) 0.88

Specific thymus-derived (T) cell recognition of papova virus-transformed cells. J Immunol (1982) 0.88

Lyme borreliosis: a relapsing fever-like disease? Scand J Infect Dis Suppl (1991) 0.88

Platelet activation by a relapsing fever spirochaete results in enhanced bacterium-platelet interaction via integrin alphaIIbbeta3 activation. Mol Microbiol (2001) 0.87

Oligodendroglioma. The Princess Margaret Hospital experience (1958-1984). Cancer (1993) 0.87

Malignant astrocytoma: hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer (1982) 0.87

Management of medullary carcinoma of the thyroid. Am J Surg (1982) 0.86

Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys (1981) 0.85

Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen. J Immunol (1983) 0.85

Regulation of the immune response to tumor antigen. VIII. The effects of host specific anti-I-J antibodies on the immune response to tumors of different origin. Cell Immunol (1980) 0.85

Diagnostic tests in Lyme borreliosis. Scand J Infect Dis Suppl (1991) 0.85

Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys (1994) 0.85

Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J Immunol (1987) 0.83

Effect of Yersinia pestis infection on temperature preference and movement of the Oriental rat flea (Xenopsylla cheopis) (Siphonaptera: Pulicidae). J Med Entomol (1993) 0.83

Regulation of the immune response to antigens on the malignant cell surface. Springer Semin Immunopathol (1982) 0.83

Canadian survey of thyroid cancer. Can Med Assoc J (1985) 0.83

Lyme disease agent in Egypt? Trans R Soc Trop Med Hyg (1990) 0.83

Analysis of disagreement in the evaluation of clinical products. J Dent Educ (1982) 0.82

Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Br J Radiol (1994) 0.82

Monoclonal antibodies to tissue-specific cell surface antigens. I. Characterization of an antibody to a prostate tissue antigen. Clin Immunol Immunopathol (1984) 0.82

The influence of ultraviolet light irradiation on the immune system. Clin Immunol Immunopathol (1980) 0.82

Interstitial cystitis and Borrelia burgdorferi. Ann Intern Med (1989) 0.81

Crossreactive neutralizing antibodies induced by immunization with caprine arthritis-encephalitis virus surface glycoprotein. Vaccine (2000) 0.81